These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 18488222)

  • 21. PDGFRβ-specific affibody-directed delivery of a photosensitizer, IR700, is efficient for vascular-targeted photodynamic therapy of colorectal cancer.
    Shi Q; Tao Z; Yang H; Fan Q; Wei D; Wan L; Lu X
    Drug Deliv; 2017 Nov; 24(1):1818-1830. PubMed ID: 29182023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determination of optimal drug dose and light dose index to achieve minimally invasive focal ablation of localised prostate cancer using WST11-vascular-targeted photodynamic (VTP) therapy.
    Moore CM; Azzouzi AR; Barret E; Villers A; Muir GH; Barber NJ; Bott S; Trachtenberg J; Arumainayagam N; Gaillac B; Allen C; Schertz A; Emberton M
    BJU Int; 2015 Dec; 116(6):888-96. PubMed ID: 24841929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endoscopic vascular targeted photodynamic therapy with the photosensitizer WST11 for benign prostatic hyperplasia in the preclinical dog model.
    Chevalier S; Cury FL; Scarlata E; El-Zayat E; Hamel L; Rocha J; Zouanat FZ; Moussa S; Scherz A; Elhilali M; Anidjar M
    J Urol; 2013 Nov; 190(5):1946-53. PubMed ID: 23680311
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering a photosensitizer nanoplatform for amplified photodynamic immunotherapy via tumor microenvironment modulation.
    Zhou Y; Ren X; Hou Z; Wang N; Jiang Y; Luan Y
    Nanoscale Horiz; 2021 Feb; 6(2):120-131. PubMed ID: 33206735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
    Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
    Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of localized prostate cancer using WST-09 and WST-11 mediated vascular targeted photodynamic therapy-A review.
    Kawczyk-Krupka A; Wawrzyniec K; Musiol SK; Potempa M; Bugaj AM; Sieroń A
    Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):567-74. PubMed ID: 26467273
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Photodynamic therapy and anti-tumor immunity.
    Gollnick SO; Owczarczak B; Maier P
    Lasers Surg Med; 2006 Jun; 38(5):509-15. PubMed ID: 16788921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular and cellular targeting for photodynamic therapy.
    Chen B; Pogue BW; Hoopes PJ; Hasan T
    Crit Rev Eukaryot Gene Expr; 2006; 16(4):279-305. PubMed ID: 17206921
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TOOKAD(®) Soluble vascular-targeted photodynamic (VTP) therapy: determination of optimal treatment conditions and assessment of effects in patients with localised prostate cancer.
    Azzouzi AR; Barret E; Moore CM; Villers A; Allen C; Scherz A; Muir G; de Wildt M; Barber NJ; Lebdai S; Emberton M
    BJU Int; 2013 Oct; 112(6):766-74. PubMed ID: 24028764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Photosensitizer IR700DX-6T- and IR700DX-mbc94-mediated photodynamic therapy markedly elicits anticancer immune responses during treatment of pancreatic cancer.
    Zhang D; Xie Q; Liu Y; Li Z; Li H; Li S; Li Z; Cui J; Su M; Jiang X; Xue P; Bai M
    Pharmacol Res; 2021 Oct; 172():105811. PubMed ID: 34390852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aggregation-Induced Emission Photosensitizer-Engineered Anticancer Nanomedicine for Synergistic Chemo/Chemodynamic/Photodynamic Therapy.
    Yu B; Liu M; Jiang L; Xu C; Hu H; Huang T; Xu D; Wang N; Li Q; Tang BZ; Huang X; Zhang W
    Adv Healthc Mater; 2024 Apr; 13(11):e2303643. PubMed ID: 38115727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The microenvironment effect on the generation of reactive oxygen species by Pd-bacteriopheophorbide.
    Vakrat-Haglili Y; Weiner L; Brumfeld V; Brandis A; Salomon Y; McLlroy B; Wilson BC; Pawlak A; Rozanowska M; Sarna T; Scherz A
    J Am Chem Soc; 2005 May; 127(17):6487-97. PubMed ID: 15853357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour irradiation combined with vascular-targeted photodynamic therapy enhances antitumour effects in pre-clinical prostate cancer.
    Sjoberg HT; Philippou Y; Magnussen AL; Tullis IDC; Bridges E; Chatrian A; Lefebvre J; Tam KH; Murphy EA; Rittscher J; Preise D; Agemy L; Yechezkel T; Smart SC; Kinchesh P; Gilchrist S; Allen DP; Scheiblin DA; Lockett SJ; Wink DA; Lamb AD; Mills IG; Harris A; Muschel RJ; Vojnovic B; Scherz A; Hamdy FC; Bryant RJ
    Br J Cancer; 2021 Aug; 125(4):534-546. PubMed ID: 34155340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of effective antitumor vaccines using photodynamic therapy.
    Gollnick SO; Vaughan L; Henderson BW
    Cancer Res; 2002 Mar; 62(6):1604-8. PubMed ID: 11912128
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment Effects of WST11 Vascular Targeted Photodynamic Therapy for Urothelial Cell Carcinoma in Swine.
    Murray KS; Winter AG; Corradi RB; LaRosa S; Jebiwott S; Somma A; Takaki H; Srimathveeravalli G; Lepherd M; Monette S; Kim K; Scherz A; Coleman JA
    J Urol; 2016 Jul; 196(1):236-43. PubMed ID: 26860792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.
    Ohshio Y; Teramoto K; Hanaoka J; Tezuka N; Itoh Y; Asai T; Daigo Y; Ogasawara K
    Cancer Sci; 2015 Feb; 106(2):134-42. PubMed ID: 25483888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antitumor effect of photodynamic therapy with a novel targeted photosensitizer on cervical carcinoma.
    Li PX; Mu JH; Xiao HL; Li DH
    Oncol Rep; 2015 Jan; 33(1):125-32. PubMed ID: 25376180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts.
    Koudinova NV; Pinthus JH; Brandis A; Brenner O; Bendel P; Ramon J; Eshhar Z; Scherz A; Salomon Y
    Int J Cancer; 2003 May; 104(6):782-9. PubMed ID: 12640688
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ immunogenic clearance induced by a combination of photodynamic therapy and rho-kinase inhibition sensitizes immune checkpoint blockade response to elicit systemic antitumor immunity against intraocular melanoma and its metastasis.
    Kim S; Kim SA; Nam GH; Hong Y; Kim GB; Choi Y; Lee S; Cho Y; Kwon M; Jeong C; Kim S; Kim IS
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479026
    [TBL] [Abstract][Full Text] [Related]  

  • 40. T-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?
    Anzengruber F; Avci P; de Freitas LF; Hamblin MR
    Photochem Photobiol Sci; 2015 Aug; 14(8):1492-1509. PubMed ID: 26062987
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.